- New contributors reflecting broader international authorship and even greater expertise
- Greater emphasis throughout on the clinical importance and application of information about cytogenetic and molecular aberrations
- Includes a complete coverage of chromosome aberrations in cancer based on an assessment of the 60,000 neoplasms cytogenetically investigated to date
- Now produced in full color for enhanced clarity
- Covers how molecular genetic data (PCR-based and sequencing information) are collated with the cytogenetic data where pertinent
- Discusses how molecular cytogenetic data (based on studies using FISH, CGH, SNP, etc) are fused with karyotyping data to enable an as comprehensive understanding of cancer cytogenetics as is currently possible